Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ZD-0892 is a selective and poten neutrophil elastaset inhibitor(human neutrophil elastase and porcine pancreatic elastase with Kis of 6.7 and 200 nM, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | ZD-0892 is a selective and poten neutrophil elastaset inhibitor(human neutrophil elastase and porcine pancreatic elastase with Kis of 6.7 and 200 nM, respectively). |
Targets&IC50 | Neutrophil elastase (human):200 nM (ki), Neutrophil elastase (human):ki: 6.7 nM |
In vivo | Administration of ZD0892 to DBA/2 mice infected with EMC virus can reduce the elastic dissolution activity of myocardium and coronary microvascular perfusion injury. ZD0892 decreases the pathologic severity of the myocardial lesions associated with murine viral myocarditis[1]. ZD-0892 can reverse advanced pulmonary vascular disease produced in rats[2]. |
Molecular Weight | 499.52 |
Formula | C24H32F3N3O5 |
CAS No. | 171964-73-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ZD-0892 171964-73-1 PI3K/Akt/mTOR signaling PI3K ZD 0892 ZD0892 inhibitor inhibit